'We're in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make payroll

By Fortune
| August 01, 2023

Psychedelics companies aren't living up to the hype, and are starting to consolidate as a flood of money into companies seeking to win regulatory approval of drugs like LSD, psilocybin and ayahuasca dries up.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...